Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 27 Jan 2025

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature

in Cancer Immunity and Immunotherapy

Yong Huang
Huibin Li
Zhifu Wei
Wanshan He
Bin Chen
Shuang Cheng
Zhifang Zhao
Lv Deng
Xiaohua Chen
Yu Lin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1492541

811 views

Original Research

Published on 27 Jan 2025

Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer

in Cancer Immunity and Immunotherapy

Ning Zhang
Chunyu Li
Zehua Zhao
Biying Jiang
Wentao Wang
Fujing Sun
Yong Zhang
Yanmei Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1497004

566 views

Editorial

Published on 27 Jan 2025

Editorial: Antigen presentation in cancer immune responses

in Cancer Immunity and Immunotherapy

Marie-Liesse Asselin-Labat
Megan K. Ruhland
Stephen T. Ferris

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558249

522 views

Original Research

Published on 27 Jan 2025

T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy

in Cancer Immunity and Immunotherapy

Meng-Tung Hsu
Gerald Willimsky
Leo Hansmann
Thomas Blankenstein

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518691

673 views

Original Research

Published on 27 Jan 2025

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning

in Cancer Immunity and Immunotherapy

Shuxian Pan
Zibing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1516524

813 views

Original Research

Published on 27 Jan 2025

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Angela J. Yoon
Richard D. Carvajal
Evan M. Graboyes
John M. Kaczmar
William G. Albergotti
Alexandra E. Kejner
Scott H. Troob
Elizabeth Philipone
Jean-Sebastien Anoma
Kent E. Armeson

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530262

761 views

Original Research

Published on 27 Jan 2025

A preoperative predictive model based on multi-modal features to predict pathological complete response after neoadjuvant chemoimmunotherapy in esophageal cancer patients

in Cancer Immunity and Immunotherapy

Yana Qi
Yanran Hu
Chengting Lin
Ge Song
Liting Shi
Hui Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530279

726 views

Original Research

Published on 27 Jan 2025

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy

in Cancer Immunity and Immunotherapy

Jian Huang
Shuangna Song
Yihua Yin
Yinyan He
Huimin Wang
Ye Gu
Laman He
Xintao Wang
Xiaocao Miao
Zhigang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528532

654 views

Case Report

Published on 27 Jan 2025

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review

in Cancer Immunity and Immunotherapy

Genlin Lu
Jiarui Tu
Jinming Tu
Renya Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1513604

812 views

Correction

Accepted on 24 Jan 2025

Immune Monitoring of Trabectedin Therapy in Refractory Soft Tissue Sarcoma Patients -the IMMUNYON Study

in Cancer Immunity and Immunotherapy

Paulo Rodrigues-Santos

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562345

Review

Published on 24 Jan 2025

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects

in Cancer Immunity and Immunotherapy

Zhi-Xun Guo
Jia-Li Ma
Jin-Qiu Zhang
Ling-Ling Yan
Ying Zhou
Xin-li Mao
Shao-Wei Li
Xian-Bin Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524801

759 views

Review

Published on 24 Jan 2025

The success of the tumor immunotherapy: neutrophils from bench to beside

in Cancer Immunity and Immunotherapy

Meng Zhu
Ru Jia
Xiaojie Zhang
Pingwei Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524038

856 views

Review

Published on 24 Jan 2025

From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments

in Cancer Immunity and Immunotherapy

Zhenlin Li
Fangqi Lu
Fujin Zhou
Dekun Song
Lunhui Chang
Weiying Liu
Guorong Yan
Guolong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518633

733 views

Original Research

Published on 24 Jan 2025

Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors

in Cancer Immunity and Immunotherapy

Gulfiya Kadyrzhanova
Miho Tamai
Shukla Sarkar
Rajkumar Singh Kalra
Hiroki Ishikawa

Frontiers in Immunology

doi 10.3389/fimmu.2025.1484303

1,016 views

Case Report

Published on 24 Jan 2025

Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node

in Cancer Immunity and Immunotherapy

Yu Xia
Yu Huang
Zheng Liu
Siyuan Song
Yi Wang
Jing Luo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1548102

477 views

Original Research

Published on 24 Jan 2025

The association of systemic immune-inflammation index with incident breast cancer and all-cause mortality: evidence from a large population-based study

in Cancer Immunity and Immunotherapy

Yu Li
Meng Yu
Ming Yang
Jingqi Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528690

812 views

Navigation group

Articles

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature

Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer

Editorial: Antigen presentation in cancer immune responses

T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

A preoperative predictive model based on multi-modal features to predict pathological complete response after neoadjuvant chemoimmunotherapy in esophageal cancer patients

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review

Immune Monitoring of Trabectedin Therapy in Refractory Soft Tissue Sarcoma Patients -the IMMUNYON Study

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects

The success of the tumor immunotherapy: neutrophils from bench to beside

From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments

Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors

Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node

The association of systemic immune-inflammation index with incident breast cancer and all-cause mortality: evidence from a large population-based study